v3.25.4
Consolidated Statements of Operations - USD ($)
12 Months Ended
Oct. 31, 2025
Oct. 31, 2024
Total Revenue $ 2,056,818 $ 1,855,644
Cost of Goods Sold (483,340) (426,189)
Gross Profit 1,573,478 1,429,455
Operating Costs and Expenses:    
Selling, General and Administrative 6,063,539 6,623,878
Research and Development 533,028 618,270
Write-off of Offering Costs 2,656,962
Impairment Expense 683,394
Loss From Operations (5,023,089) (9,153,049)
Other Expense:    
Interest Expense (2,971,213) (4,242,595)
Gain on Forgiveness of Debt 343,938
Gain (Loss) on Extinguishment of Debt (3,694,493) 740,724
Unrealized Gain on Derivative/Warrant Liability 493,055 2,781,360
Net Loss (10,851,802) (9,873,560)
Net Loss Available to Common Stockholders $ (10,868,218) $ (9,873,560)
Net Loss per Common Share, Basic $ (2.44) $ (2.21)
Net Loss per Common Share, Diluted $ (2.44) $ (2.21)
Shares Used in Computing Net Loss per Common Share, Basic 4,460,535 4,459,224
Shares Used in Computing Net Loss per Common Share, Diluted 4,460,535 4,459,224
Series A One Preferred Stock [Member]    
Other Expense:    
Cumulative Series A-1 Convertible Preferred Stock Dividend Requirement $ (16,416)
Product [Member]    
Total Revenue 2,020,818 1,821,894
Product Sales Related Parties [Member]    
Total Revenue $ 36,000 $ 33,750